• Search
  • Advanced Search
Korean J Hepatol > Volume 13(4); 2007 > Article
7
The Korean Journal of Hepatology 2007;13(4): 576-580.
doi: https://doi.org/10.3350/kjhep.2007.13.4.576
The Korean Journal of The Efficacy of Sorafenib for Patients With Advanced Hepatocellular Carcinoma
Jeong Heo
Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea
KeyWords: Carcinoma, hepatocellular; Tyrosine kinases inhibitor; Sorafenib
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 3,619 View
  • 21 Download
Related articles

Letter “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study”

Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study

Development of risk scores for prognosis prediction among patients with early-stage hepatocellular carcinoma2025 January;31(1)

Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation2025 February;31(Suppl)

Correspondence to editorial on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”2024 October;30(4)

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 2291
TOTAL : 2696706
Close layer